• 
  Anthime Flaus, Remi Philippe, Stephane Thobois, Marc Janier, Christian Scheiber. Semi-quantitative analysis of visually normal 123I-FP-CIT across three large databases revealed no difference between control and patients. EJNMMI Research, 2023, 13, ⟨10.1186/s13550-023-00983-6⟩. ⟨hal-04776527⟩
• 
  Deborah Ziri, Laurent Hugueville, Claire Olivier, Philippe Boulinguez, Harish Gunasekaran, et al.. Inhibitory control of gait initiation in humans: An electroencephalography study. Psychophysiology, 2024, 61 (11), pp.e14647. ⟨10.1111/psyp.14647⟩. ⟨hal-04751938⟩
• 
  Jean-Loup Méreaux, Claire-Sophie Davoine, David Pellerin, Giulia Coarelli, Marie Coutelier, et al.. Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions. EBioMedicine, 2024, 99, pp.104931. ⟨10.1016/j.ebiom.2023.104931⟩. ⟨hal-04393590v2⟩
• 
  Eva Martinez, Benjamin Pasquereau, Guillaume Drui, Yosuke Saga, Elise Météreau, et al.. Ventral striatum supports Methylphenidate therapeutic effects on impulsive choices expressed in temporal discounting task. Scientific Reports, 2020, 10 (1), pp.716. ⟨10.1038/s41598-020-57595-6⟩. ⟨hal-03025239⟩
• 
  Mathilde Pitoy, Lisa Gauthier, Justine Debatisse, Julie Maulavé, Elise Météreau, et al.. SB-258585 reduces food motivation while blocking 5-HT$_6$ receptors in the non-human primate striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2024, 131, pp.110970. ⟨10.1016/j.pnpbp.2024.110970⟩. ⟨hal-04566627⟩
• 
  Mathilde Millot, Yosuke Saga, Sandra Duperrier, Elise Météreau, Maude Beaudoin-Gobert, et al.. Prior MDMA administration aggravates MPTP-induced Parkinsonism in macaque monkeys. Neurobiology of Disease, 2020, 134, pp.104643. ⟨10.1016/j.nbd.2019.104643⟩. ⟨hal-04566672⟩
• 
  Garance M Meyer, Josep Marco-Pallarés, Philippe Boulinguez, Guillaume Sescousse. Electrophysiological underpinnings of reward processing: Are we exploiting the full potential of EEG?. NeuroImage, 2021, 242 (4), pp.118478. ⟨10.1016/j.neuroimage.2021.118478⟩. ⟨hal-04566642⟩
• 
  Chloé Laurencin, Sophie Lancelot, Sarah Brosse, Inés Mérida, Jérôme Redouté, et al.. Noradrenergic alterations in Parkinson's disease: a combined 11 C-yohimbine PET/neuromelanin MRI study. Brain - A Journal of Neurology , 2023, ⟨10.1093/brain/awad338⟩. ⟨hal-04441098v2⟩
• 
  Mathilde Renaud, Maria-Ceu Moreira, Bondo Ben Monga, Diana Rodriguez, Rabab Debs, et al.. Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1. JAMA neurology, 2018, 75 (4), pp.495. ⟨10.1001/jamaneurol.2017.4373⟩. ⟨hal-02438841⟩
• 
  Chloé Laurencin, Noémie Timestit, Ana Marques, Domitille Dilly Duchez, Caroline Giordana, et al.. Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial. Journal of Neurology, 2023, 270, pp.4851 - 4859. ⟨10.1007/s00415-023-11814-y⟩. ⟨hal-04274916⟩

28